Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #2870
Reference
Drug alert no 6/2008
Name
Drug alert no 6: class 2
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
EFFECTIVENESS
DRUG THERAPY
PHARMACEUTICAL SERVICES
PHARMACEUTICAL INDUSTRY
Description
Attaches drug safety information from the Medicines and Healthcare Products Regulatory Agency (MHRA) for onward transmission. Novartis Vaccines and Diagnostics S.r.l. are recalling two batches of Menjugate Kit as a precaution following an initial failure of a sterility test carried out as part of a shipping validation study of the batch of aluminium hydroxide solvent used in them.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Pharmacy Division, Primary and Community Care Directorate, St Andrew’s House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2009-02-26 00:00:00
Click to go back to homepage